SELECTA BIOSCIENCES INC's ticker is SELB and the CUSIP is 816212104. A total of 45 filers reported holding SELECTA BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61,440 | -1.9% | 57,962 | +3.7% | 0.00% | – |
Q2 2023 | $62,610 | +11.8% | 55,902 | +22.3% | 0.00% | – |
Q1 2022 | $56,000 | -64.8% | 45,702 | -6.6% | 0.00% | -100.0% |
Q4 2021 | $159,000 | -23.2% | 48,917 | -1.6% | 0.00% | 0.0% |
Q3 2021 | $207,000 | -1.0% | 49,703 | -0.7% | 0.00% | 0.0% |
Q2 2021 | $209,000 | +16.8% | 50,051 | +26.6% | 0.00% | 0.0% |
Q1 2021 | $179,000 | +50.4% | 39,523 | +0.3% | 0.00% | – |
Q4 2020 | $119,000 | +17.8% | 39,419 | -2.8% | 0.00% | – |
Q3 2020 | $101,000 | -14.4% | 40,550 | -2.2% | 0.00% | -100.0% |
Q2 2020 | $118,000 | +126.9% | 41,473 | +90.1% | 0.00% | – |
Q1 2019 | $52,000 | +62.5% | 21,814 | +84.1% | 0.00% | – |
Q4 2018 | $32,000 | -82.8% | 11,852 | -0.8% | 0.00% | -100.0% |
Q3 2018 | $186,000 | +20.0% | 11,943 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $155,000 | +68.5% | 11,728 | +30.2% | 0.00% | – |
Q1 2018 | $92,000 | 0.0% | 9,005 | -4.0% | 0.00% | – |
Q4 2017 | $92,000 | -35.7% | 9,378 | +19.4% | 0.00% | -100.0% |
Q3 2017 | $143,000 | -0.7% | 7,857 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $144,000 | +220.0% | 7,269 | +133.0% | 0.00% | – |
Q1 2017 | $45,000 | – | 3,120 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,627,527 | $29,702,000 | 25.53% |
Vivo Capital, LLC | 1,119,189 | $20,425,000 | 4.13% |
GREAT POINT PARTNERS LLC | 901,847 | $16,459,000 | 3.20% |
Silver Rock Financial LP | 677,025 | $12,356,000 | 1.65% |
HAMILTON LANE ADVISORS LLC | 91,125 | $1,663,000 | 1.14% |
Perceptive Advisors | 2,324,650 | $42,424,000 | 0.81% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 951,629 | $17,367,000 | 0.78% |
Opaleye Management Inc. | 95,000 | $1,733,000 | 0.61% |
SPHERA FUNDS MANAGEMENT LTD. | 228,534 | $4,171,000 | 0.60% |
Orbimed Advisors | 1,842,797 | $33,631,000 | 0.32% |